Publicacións en colaboración con investigadores/as de Toronto General Hospital (3)

2024

  1. Effect of Avenciguat on Albuminuria in Patients with CKD Two Randomized Placebo-Controlled Trials

    Journal of the American Society of Nephrology, Vol. 35, Núm. 9, pp. 1227-1239

2020

  1. Rationale and protocol of the Dapagliflozin and Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial

    Nephrology Dialysis Transplantation, Vol. 35, Núm. 2, pp. 274-282

  2. The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 35, Núm. 10, pp. 1700-1711